This company analysis examines Altana's market position and future outlook. The profile encompasses global and US specific company strategy, portfolio and pipeline analysis, and an assessment of financial performance, with US, rest of world and global forecasts for key drugs to 2010. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

• Benchmark Altana's current and future strategic performance against its peers in the pharmaceutical industry
• Assess the key drivers and resistors to Altana's growth over the next six years
• Explore the development of Altana's major therapeutic franchises and discover the potential of key pipeline products to 2010